The Anthem Biosciences IPO, starting July 14, 2025, aims to raise ₹3,395 crore through an Offer for Sale of 5.96 crore shares ...

The recently opened IPO's GMP stood at Rs 105, as per the data till 12:32 pm. Its price band is likely to stay near Rs 570.

Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ₹3,395 crore offer is entirely for sale by ...

According to market observers, shares of the company are available at a premium of ₹101 in the grey market today ...

JM Financial Limited is acting as the book-running lead manager to the issue, and KFin Technologies Limited is the registrar.

Ahead of the initial share sale opening for public subscription, the unlisted shares of Anthem Biosciences were trading at ...

Anthem Biosciences IPO receives tepid response, retail investors show interest, SBI Securities recommends long-term ...

Anthem Biosciences is selling its shares in the price band of Rs 540-570, which could be applied for a minimum of 26 shares and its multiples to raise a total of Rs 3,395 crore between July 14-16.

The company offers integrated services across the drug discovery, development, and manufacturing lifecycle for both NCEs and ...

Ahead of the issue launch, Anthem Biosciences has raised ₹1,016 crore from 60 institutional investors via its anchor book on ...

The mainboard issue of the research-driven drug manufacturer opens for subscription on July 14. Here's everything you must ...